Apollo Strategic Growth Capital II (NYSE:APGB) announced this morning that it has postponed its April 28 special meeting to 9 am ET on May 5.
Shareholders will be voting on a proposal to allow Apollo Strategic to extend its transaction deadline up to nine months from May 12, 2023 to February 12, 2024. Shareholders will have until May 3 to redeem their shares.
Apollo Strategic II also today announced that it entered into a non-redemption agreement with an unaffiliated third party. Under the non-redemption agreement, the investor agreed not to redeem an aggregate of 1,500,000 non-redeemed shares at the meeting, in exchange for which commitment the sponsor has agreed to transfer to the investor an aggregate of 300,000 Class B ordinary shares. The agreement is not expected to increase the likelihood that the extension proposal is approved by shareholders but will increase the amount of funds that remain in the trust account following the meeting.
The SPAC raised a total of $690 million in its February 2021 IPO, and originally had 24 months to complete a deal with the right to auto-extend up to three months.
It has not yet announced a combination agreement, but intends to combine with a leading company that exhibits positive top-line growth that is not reliant on leverage. Apollo II is led by CEO Sanjay Patel, Executive Chairman Scott Kleinman and CFO and Chief Acccounting Officer James Crossen.
Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity,...
Lakeshore Acquisition III Corp. (NASDAQ:LCCCU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LCCCU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target with a team that has previously closed business combinations in the...
Churchill Capital Corp X (NASDAQ:CCCXU) has filed for a $300 million SPAC with a broad search focus, to add to the portfolio of Churchill deals. Five Churchill deals have closed (I, II, III, IV, and AltC), while V, VI and VII liquidated in the SPAC downturn. However, keep in mind that the Churchill team still...
Black Hawk Acquisition Corp (NASDAQ:BKHA) has entered into a definitive agreement to combine with biotech firm Vesicor Therapeutics at a pre-money equity value of $70 million. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. The combined company is expected to...
At the SPAC of Dawn SPAC activity has continued to heat up as the market now has a new business combination to digest alongside two new SPACs making their debut on the Nasdaq later today. Three more new SPACs have filed their initial S-1s to eventually join them. That makes 29 SPAC IPOs and 49...